What is AccuRx?
AccuRx operates as a comprehensive communication platform designed to bridge the gap between patients and healthcare professionals. By facilitating seamless data exchange and coordination, the software has achieved near-ubiquitous adoption, currently utilized by 98% of GP practices and 68% of NHS trusts. The platform's core value proposition lies in its ability to streamline complex workflows, thereby enhancing the efficiency of patient management across primary, secondary, community, and mental health services. Through its integrated care initiatives, AccuRx has effectively transformed the digital interface of the NHS, positioning itself as an essential utility for modern medical administration and patient engagement.
How much funding has AccuRx raised?
AccuRx has raised a total of $38.1M across 1 funding round:
Series B
$38.1M
Series B (2021): $38.1M with participation from British Patient Capital, Latitude VS, and Lakestar
Key Investors in AccuRx
British Patient Capital
A government-owned economic bank specializing in providing equity finance and support to UK-based businesses, focusing on long-term growth and market development.
Lakestar
A prominent European venture capital firm that partners with visionary entrepreneurs in sectors such as Healthcare and Deep Tech, providing support from Seed to Growth stages.
Latitude VS
A venture capital firm focused on supporting high-growth technology companies, providing the necessary capital and strategic guidance to scale operations effectively.
What's next for AccuRx?
With the recent influx of capital, AccuRx is well-positioned to accelerate its product roadmap and deepen its penetration into integrated care systems. The strategic focus will likely shift toward enhancing interoperability between disparate healthcare data silos and scaling its software suite to meet the evolving demands of a post-pandemic medical landscape. By leveraging its strong market position and the support of its institutional partners, the company is poised to drive further innovation in patient-centric digital health solutions, potentially exploring new avenues for international expansion or specialized clinical modules that further optimize the delivery of care.
See full AccuRx company page
